Clinicopathological features and prognosis of small cell carcinoma of the cervix

Abstract

Small cell carcinoma of cervix (SCCC) is a rare disease with highly aggressive behaviour and is pathologically hard to diagnose. In this study, the clinicopathological features, diagnosis, treatment and prognosis of the condition were examined. Clinical records and follow-up data of 7 cases of SCCC were retrospectively studied. Our results showed that five non-recurrent cases initially presented irregular vaginal bleeding or increased apocenosis of varying degrees. Pathological examination revealed that the stroma was diffusely infiltrated with small monomorphous cells ranging from round to oval shape. Three cases were immunohistochemically confirmed. One case was accompanied with squamous cell cancer. Of the 7 cases, one case was classified as stage I b1, two stage I b2, one stage IIa, one stage IIb, and one stage IIIb. On the basis of their stages of condition, one subject with stage III b underwent chemotherapy, and one with stage Ib2 received extensive hysterectomy plus pelvic lymphadenectomy, while the other 5 cases were treated by extensive hysterectomy and pelvic lymphadenectomy in combination with pre- and/or post-operative adjuvant chemotherapy and radiotherapy. Of the 7 patients, 4 had relapse-free survival of 14, 14, 16 and 28 months respectively. It is concluded that SCCC is an aggressive tumor with propensity for early pelvis lymph node metastases. Early-stage patients should be treated by extensive hysterectomy and pelvic lymphadenectomy in combination with pre- and/or post-operative adjuvant chemotherapy and radiotherapy.

Keywords

cervix / small cell carcinoma / clinicopathological features / prognosis

References

[1] FattanehA., TavassoliP., DevileeL.. . WHO classification tumors of the breast and female genital organs, 2003, France, IARC Press, 262-279

[2] LianL.J.. . Lin Qiaozhi Gynecolgoic Oncology (Chinese), 2000, Beijing, People’s Health Publishing House, 250

[3] ChangT.C., LaiC.H., TsengC.J., et al.. Prognosis factors in surgically treated small cervical carcinoma followed by adjuvant chemotherapy. Cancer, 1998, 83(4): 712-718

[4] ScullyR.E., AguirreP., DeLellisR.A.. Argyrophilia, serotonin, and peptide hormones in the female genital tract and its tumors. Int J Gynecol Pathol, 1984, 3(1): 51-70

[5] GrumC.P.. The molecular biology of neuroendocrine cervical carcinoma: we are witnessing early or late events. Gynecol Oncol, 1999, 72(1): 1-2

[6] LemuraK., SonodaT., HayakawaA., et al.. Small cell carcinoma of the uterine cervix showing Cushing’s syndrome caused by ectopic adrenocorticotopin hormone production. Jpn J Clin Oncol, 1991, 21(4): 293-298

[7] Van NagellJ.R., DonaldsonE.S., WoodE.G., et al.. Small cell cancer of the uterine cervix. Cancer, 1977, 40(5): 2243-2249

[8] SevinB.U., MethodM.W., NadjiM., et al.. Efficacy of radical hysterectomy as treatment for patients with small cell carcinoma of the cervix. Cancer, 1996, 77(8): 1489-1493

[9] ROSAJ. . Rosai and Ackerman Surgical Pathology (Chinese), 19998th ed.Shenyang, Liaoning Education Publishing House, 1375-1377

[10] HashiA., YasumizuT., YodaI., et al.. A case of small cell carcinoma of the uterine cervix presenting Cushing’s syndrome. Gynecol Oncol, 1996, 61(3): 427-431

[11] SternbergS.S.. . Diagnostic Surgical Pathology (Chinese), 20032rd ed. EditionBeijing, Peking University Medical Press, 2174-2177

[12] IshidaG.M., KatoN., HayasakaT., et al.. Small cell neuroendocrine carcinomas of the uterine cervix: a histological, immunohistochemical and molecular genetic study. Int J Gynecol Pathol, 2004, 23(4): 366-372

[13] AbelerV.M., HolmR., NeslandJ.M., et al.. Small cell carcinoma of the cervix: A clinicopathologic study of 26 patients. Cancer, 1994, 73(3): 672-677

[14] HerringtonC.S., GrahamD., SouthernS.A., et al.. Loss of retinoblastoma protein expression is frequent in small cell neuroendocrine carcinoma of the cervix and is unrelated to HPV type. Hum Pathol, 1999, 30(8): 906-910

[15] StolerM.H., MillsS.E., GersellD.J., et al.. Small-cell neuroendocrine carcinoma of the cervix. A human papillomavirus type 18-associated cancer. Am J Surg Pathol, 1991, 15(1): 28-32

[16] TianY.S.. . Gynecologic Oncology: Clinical Pathology (Chinese), 2001, Beijing, People’s Health Publishing House, 117-118

[17] WuZ.B., YangG.H.. . China Surgical Pathology, 20022rd.Beijing, People’s Health Publishing House, 1232

[18] Albores-SaavedraJ., LatifS., CarrickK.S., et al.. CD56 reactivity in small cell carcinoma of the uterine cervix. Int J Gynecol Pathol, 2005, 24(2): 113-117

[19] YuA.J., ZhangP., LouH.K.. Clinicopathological features of Small-sell carcinoma of the cervix and its treatment. Chin J Oncol (Chinese), 2002, 24(4): 400-403

[20] HoskinsP.J., SwenertonK.D., PikeJ.A., et al.. Small-sell carcinoma of the cervix: Fourteen years of experience at a single institution using a combined-modality regimen of involved-field irradiation and platinum-based combination chemotherapy. J Clin Oncol, 2003, 21(18): 3495-3501

[21] FujitaT., KiyamaM., TomizawaY., et al.. Comprehensive analysis of p53 gene mutation characteristics in lung carcinoma with special reference to histological subtypes. Int J Oncol, 1999, 15(5): 927-934

[22] ChanJ.K., LoizziV., BurgerR.A., et al.. Prognostic factors in neuroendocrine small cell cervical carcinoma: A multivariate analysis. Cancer, 2003, 97(3): 568-574

[23] ViswanathanA.N., DeaversM.T., JhingranA., et al.. Small cell neuroendocrine carcinoma of the cervix: Outcome and patterns of recurrence. Gynecol Oncol, 2004, 93(1): 27-33

[24] TsunodaS., JoboT., AraiM., et al.. Small-cell carcinoma of the uterine cervix: a clinicopathologic study of 11 cases. Int J Gynecol Cancer, 2005, 15(2): 295-300